Category Archives: MS Treatment

14-03-2012 19:48 Need treatment for MS Contin? Call 1-800-303-2938 or you can simply visit our website to get whatever type of information it is you need on the dangerous drug MS Contin and MS Contin Abuse. MS Contin, which is meant to manage pain, is abused way more than most people realize, and it is very addictive. So if you or a loved one are struggling with MS Contin Abuse - you should get help as soon as possible. Go here to read the rest: MS Contin Abuse Treatment … Continue reading →

Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- … Continue reading →

BOSTON, March 14, 2012 /PRNewswire/ --MAKScientific, LLC, a privately held company focused on the discovery of novel therapeutics modulating cannabinoid pathways, today announced that it has entered into an exclusive, worldwide option and collaboration agreement with Biogen Idec (NASDAQ: BIIB - News) to develop and commercialize drug candidates for the treatment of multiple sclerosis (MS) and other neurodegenerative diseases. Under the agreement, Biogen Idec will receive an option for an exclusive license to select discovery-stage MAKScientific drug candidates for all indications worldwide. Upon Biogen Idec's exercise of the option, MAKScientific will be eligible to receive an exercise fee of up to $3 million and up to an additional $31 million in milestone payments associated with the clinical development of the drug candidates. In addition, MAKScientific will be eligible to receive royalties on net sales worldwide. "We are very excited to initiate this collaboration with Biogen Idec," said Alexandros Makriyannis, PhD, Founder of MAKScientific. "We believe it will help advance our proprietary medicinal chemistry to the benefit of MS patients. As a global leader in MS research and development, Biogen Idec is the ideal partner for our discovery and development program." About MAKScientific. MAKScientific LLC, is a privately held, Massachusetts-based, discovery … Continue reading →

13-03-2012 11:07 Multiple sclerosis can be difficult to diagnose. Dr. Steven Bromley discussesdiagnosis and management of the disease, and the continuum of care Virtua Neurosciences offers patients -- enabling them to live healthy, happy lives. See the original post here: Managing multiple sclerosis - Video … Continue reading →

Yukoners with multiple sclerosis have a chance to participate in clinical trials for a controversial treatment. There are up to six secured spots for Yukoners for the so-called 'liberation treatment' clinical trials in Albany, New York. Initially, the territory was to take part in clinical trials in Saskatchewan. Jenny Roberts, the president of the Yukon Multiple Sclerosis Association, says its members urged the Yukon Government to get in on the treatment at the beginning. "We usually get ignored because of our geographical location, so that was our pressure that we did put on them, that, 'don't exclude us and if we have an opportunity we have to explore it'. And the YTG (Yukon Territorial Government), Minister of Health and the deputy minister has listened and worked with us very closely to get to this point," she said. Roberts says the association's members are very excited about the chance to participate in the trials. Applicants must be between 18 and 60 years old, have a valid passport and they cannot have had past liberation treatments. The therapy is also known as Zamboni therapy after it was pioneered by Italian doctor Paolo Zamboni. Zambonis procedure uses angioplasty to widen neck veins. His … Continue reading →

LONDON, March 14, 2012 /PRNewswire/ -- Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis (MS) market. This is being exacerbated by the limited availability of accurate diagnostic tools. There is, therefore, an immediate need for innovative and enhanced therapeutic and diagnostic tools that support improved diagnosis and expand the range of treatment options. New analysis from Frost & Sullivan (http://www.pharma.frost.com), Analysis of the European Multiple Sclerosis Market, finds that the market earned revenues of approximately $3.2 billion in 2010 and estimates this to reach approximately $5.38 billion in 2017, growing at a compound annual growth rate (CAGR) of 7.2 per cent from 2010-2017. The segments covered include: immunosuppressants, immunomodulators and corticosteroids. "The rising number of people suffering from MS is resulting in higher demand for therapeutics," notes Frost & Sullivan Research Analyst Deepika Pramod Chopda. "This, coupled with strong pipeline development, is pushing robust growth in the overall market." MS is characterised as a chronic disease, commonly diagnosed in patients between 20-50 years of age. It affects more than 2.5 million people across the world, with Europe accounting for nearly 550,000 cases. Significant research is currently underway to efficiently … Continue reading →

The National Multiple Sclerosis Society, North Florida Chapter is painting the town orange the official color of MS awareness during Multiple Sclerosis Awareness Week which concludes Sunday. MS Awareness Week will kicked off Monday. with an awareness and fundraising event at Bogey Grille in Ponte Vedra Beach, where the public was invited to a free screening of the movie The Ride starring The Amazing Race host Phil Keoghan cycling across the country to raise awareness for the National MS Society and Bike MS. A portion of the proceeds raised from the evenings food and beverage sales will benefit the National MS Society. Also on Monday the Alhambra Theatre spread MS awareness by lighting the garden and front yard of the theatre in orange through Sunday. The door man will also don orange attire and information about MS, the Society and Walk MS one of the Societys main annual fundraisers will be displayed. In addition, more than 50 people in the North Florida are registered with the Chapter as MS Ambassadors who will receive prizes and materials to help raise awareness in the 36 counties that the North Florida Chapter serves. They will spread awareness through email, social media and by … Continue reading →

Yukoners suffering from multiple sclerosis (MS) will have the chance to undergo clinical trials of the liberation treatment. About six Yukon residents will be chosen for the controversial treatment in Albany, N.Y., after passing a series of screenings. The procedure uses angioplasty to widen blood vessels, and is reported to improve everything from eyesight to fatigue. Its not yet legal in Canada, and many Canadians have flown to places like Costa Rica and India to undergo the procedure. Were all patting ourselves on the back for all the hard work weve done to get to this point, Jenny Roberts, a Whitehorse resident with MS and the president of the territorys MS association, told the Star today. Roberts said the association invited then-Health and Social Services minister Glen Hart and deputy minister Stuart Whitley to a monthly meeting a year ago. They wanted to learn whether the government would send Yukoners to Saskatchewan to participate in the provinces trials. The government agreed to partnering with the Saskatchewan Health Research Foundation by sending about a dozen Yukoners down south for trials. But they never happened. Once the trials fell through, we were concerned what would happen, Roberts said. These new trials involve … Continue reading →

MARTIN COUNTY,FL (WFLX) With miles of beautiful waterways, South Florida is a boating paradise. To make sure it stays the way, it's important to keep sewage from those boats out of the water. In Martin County, there's a free program that helps boaters do just that. So this story is about poop. More specifically, the "MS Poop." "I had to have something to get people kind of talking about it," laughs Darrell Schuler with the Martin County Utilities Department. "MS Poop" stands for the "Martin Ship Pump Out Operation Program." Operated by the Martin County Utilities Department, it is the "Poop's" job to keep sewage out of area waterways. It's a free service that first came into existence back in 2000. "People were trying to take care of the water but the problem back then was there just weren't enough places where people could pump out their sewage tanks conveniently," said Schuler. The county just got a state grant to keep the Poop in operation through next summer. So how does it work? The MS Poop shows up to where a vessel is docked or moored then connects a hose to the waste fitting on the vessel. About 25-35 boats … Continue reading →

Public release date: 13-Mar-2012 [ | E-mail | Share ] Contact: Carolann Murphy cmurphy@kesslerfoundation.org 973-324-8382 Kessler Foundation WEST ORANGE, N.J. -- Warm weather may hinder cognitive performance in people with multiple sclerosis (MS), according to results of a Kessler Foundation study e-published online ahead of print by Neurology. An accompanying editorial by Meier & Christodoulou, MS and heat: The smoke and the fire, details the study's unique aspects, ie, longitudinal followup in a cohort with apparently quiescent disease. Victoria M. Leavitt, Ph.D., research scientist at Kessler Foundation, is principal investigator for the study, which for the first time, shows a link between warm weather and cognition in people with MS. With more research, this information might help guide people with MS in making life decisions and assist their clinicians in choosing clinical treatment. Scientists may also want to consider the effect of warmer weather on cognition when designing and conducting clinical trials. Kessler Foundation co-investigators are James F. Sumowski, Ph.D., Research Scientist, Nancy Chiaravalloti, Ph.D., Director of Neuropsychology & Neuroscience Research, and John DeLuca, Ph.D., Vice President for Research. All also have faculty appointments at UMDNJ-New Jersey Medical School. Memory and processing speed were measured in 40 individuals with MS … Continue reading →